Unlabelled: Replicated evidence of satisfactory 1- and 2-year post-treatment outcomes has been reported for the Comprehensive Stuttering Program (CSP). However, little is known about longer term outcomes of the CSP. Yearly follow-up measures were obtained from 18 participants for 5 consecutive years. At 5-year follow-up, participants were maintaining clinically and statistically significant reductions in stuttering and increases in rates of speech relative to pre-treatment measures. Standardized effect sizes were large. There were no significant differences among the immediate post-treatment and five follow-up measures, indicating that speech gains achieved by the end of the treatment program were stable over the 5-year follow-up period. Insufficient return rates for self-report data for the third to fifth follow-up measurement occasions prohibited analyzing these data. However, non-significant differences among the immediate post-treatment and two follow-up measures indicated that improvements achieved by the end of treatment in speech-related confidence, and perceptions of struggle, avoidance, and expectancy to stutter were stable over the 2-year follow-up period. Significant differences among the speech-related communication attitudes scores indicated that improvements in attitudes made at the end of the treatment program were less stable. Taken together, these results provide further and longer term evidence of the effectiveness of the CSP.

Educational Objectives: Readers will be able to: (1) describe the main components of the Comprehensive Stuttering Program (2) describe a methodology for determining clinically meaningful maintenance of stuttering reductions, and (3) describe the durability and stability of improvements in speech and self-report measures across time.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jfludis.2010.04.002DOI Listing

Publication Analysis

Top Keywords

comprehensive stuttering
12
stuttering program
12
follow-up measures
12
longer term
8
5-year follow-up
8
differences post-treatment
8
post-treatment follow-up
8
achieved treatment
8
treatment program
8
program stable
8

Similar Publications

Article Synopsis
  • Drug-induced stuttering is an acquired speech disorder caused by certain medications, resembling developmental stuttering, and has been primarily studied through case reports and adverse drug reactions.
  • A recent study analyzed electronic health records from a major medical center to identify and classify drugs linked to this type of stuttering, reviewing 40 suspected cases.
  • The findings revealed that 18 different drugs were associated with stuttering in 22 individuals, especially in the classes of antiseizure agents, CNS stimulants, and antidepressants, with topiramate being the most commonly implicated drug; the study emphasizes the need for better documentation of medication-related speech issues in EHRs.
View Article and Find Full Text PDF

Validity and reliability of the revised scale of avoidance and struggle behaviours in stuttering (r-SASBS).

Int J Lang Commun Disord

November 2024

Department of Audiology, Faculty of Health Sciences, Baskent University, Ankara, Turkey.

Article Synopsis
  • * The r-SASBS was refined from 30 to 16 items and tested on 440 participants, showing high content validity, two main factors, and strong internal consistency and reliability in distinguishing between people who stutter and those who do not.
  • * Findings suggest the r-SASBS is a valid and reliable tool for assessing secondary behaviors in individuals who stutter, highlighting its potential use by speech-language pathologists, and recommending further validation in school-aged children.
View Article and Find Full Text PDF

The impact of electronic cigarettes on the outcomes of total joint arthroplasty.

Arch Orthop Trauma Surg

November 2024

Department of Trauma and Orthopaedic Surgery, Complex Arthroplasty Unit, St Georges University Hospital NHS Trust, London, UK.

Article Synopsis
  • Cigarette smoking negatively affects total joint arthroplasty outcomes, leading to higher pain relief needs, increased mortality, and slower healing.
  • Electronic cigarettes, a popular alternative among smokers, have not been thoroughly studied for their effects on joint surgery outcomes, prompting this review for insights.
  • The findings suggest that electronic cigarettes may harm bone health, weaken the immune system, hinder wound healing, and extend hospital stays, necessitating closer monitoring during the perioperative period.
View Article and Find Full Text PDF

Developmental Validation of the Microreader 23HS Plex ID System: A Novel Supplementary Non-CODIS STR Multiplex Assay for Forensic Application.

Electrophoresis

November 2024

Shanghai Key Laboratory of Forensic Medicine, Shanghai Forensic Service Platform, Key Laboratory of Forensic Science, Ministry of Justice, Academy of Forensic Sciences, Shanghai, China.

A novel supplementary non-CODIS STR multiplex assay designated as the "Microreader 23HS Plex ID System" was developed. The Microreader 23HS Plex ID System enables simultaneous profiling of 23 STR loci and the amelogenin locus. The majority of these loci are non-CODIS STRs (D4S2408, D9S2157, D20S161, D3S2459, D18S1364, D13S305, D1S2142, D19S400, D6S1017, D7S1517, D2S1776, D2S1360, D3S1744, D16S3391, D3S1545, D11S4463, D20S85, D1S549, D10S2325, D21S2055), with the exception of three CODIS STRs (D2S441, D12S391, and D22S1045).

View Article and Find Full Text PDF

Background: Deep grey matter pathology is a key driver of disability worsening in people with multiple sclerosis. Quantitative susceptibility mapping (QSM) is an advanced magnetic resonance imaging (MRI) technique which quantifies local magnetic susceptibility from variations in phase produced by changes in the local magnetic field. In the deep grey matter, susceptibility has previously been validated against tissue iron concentration.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!